Tuesday, February 7, 2023
HomeMalawiHealthOpinion: How will economic downturn affect health investment in the Africa?

Opinion: How will economic downturn affect health investment in the Africa?

– –

At the height of the COVID-19 pandemic, the world was primed for a substantial increase in health and biotech spending and investment.

Governments and the private sector alike promised to dedicate funding so that they would be adequately prepared for the next pandemic if or when it came.

Over the course of 2020 and 2021, those promises appeared to be materialising. Globally, healthtech companies raised US$57.2 billion in 2021, a 79% increase from the US$32 billion raised in 2020, which itself was significantly higher than the approximately US$20 billion raised in 2019.

African health and biotech startups, meanwhile, benefitted to the tune of US$392 million, an 81% increase from the investment received in 2020.

Over the course of 2022, however, the global investing landscape has changed dramatically. Spooked by geopolitical uncertainty, a bear market, and rising interest rates amid record-high inflation, investors have retreated to traditionally safer waters, with global venture capital funding hitting its lowest point in two years. Health and biotech startups have not been spared the effects of this slowdown either.

– –

Amid this investment slowdown, what is the likely impact on the African health and biotech startup ecosystem?

Investment remains strong, as does long-term potential

Those paying attention to the African VC and investment space would have cause to believe that the continent comes away unscathed. After all, African startups raised a record US$3.5 billion in the first half of 2022, a 131% increase on the same period in 2021.

Simultaneously, the continent has enjoyed a sustained recovery in economic growth post the pandemic, with Sub-Saharan Africa expected to grow 3.7% in the second half of 2022. In isolation, this level of growth is high if not remarkable.

Author Sam Sturm of Founders Factory Africa

– –

Yet, given the recessionary headwinds blowing through the global economy, especially those classed as “developed” economies, Sub-Saharan Africa is a beacon of exciting possibilities.

It’s also worth bearing in mind that, according to the African Venture Capital Association, 16 Africa-focused VCl funds announced a final or interim close in the first half of 2022, with a cumulative fundraise of close to half a billion US dollars (US$495 million).

That funding will play a vital role in supporting the growth of the  African startup ecosystem, health and biotech startups included.

Given that the African healthcare market is expected to be worth US$259 billion by 2030, that’s an opportunity that cannot be ignored.

If the economic headwinds of 2021 and 2022 do eventually impact Africa’s VC ecosystem, it should not detract from the continent’s long-term potential. That’s especially true for the health and biotech vertical, which accounted for just 8% of the US$4.9 billion raised by African tech startups in 2021.

The room for growth is exponential. Healthcare is a universal concern. In a region that’s home to nearly 1.2 billion people across 46 countries, there are numerous challenges that innovative startups are uniquely positioned to address. Our own portfolio of healthtech startups has given us a first-hand taste of the depth of innovation in the sector.

Regardless of current global economic conditions, a long-term approach that focuses on that potential can  lead to the emergence of sector-defining ventures that create real change for their users on the ground.

Even if there is a pullback in VC funding in the short-term, committed investors, including our healthtech investment partners, understand that real growth and change will be achieved over the long haul. They will be able to maximise the value their investments produce and help startups focus on building their businesses.

African health and biotech startups may find it harder to raise funding and investment in the next few years, yet these negative conditions are not permanent. They do not diminish the sector’s potential on the continent, with the winners likely to be those that back ventures that solve real problems for real people on the ground over the long term.

Author: Sam Sturm, Chief Venture Architect, Founders Factory Africa

Global Fund raises $14.25 billion to fight Malaria, HIV and TB

Source: Africa Feeds

The Maravi Post has over one billion views since its inception in December of 2009. Viewed in over 100 countries Follow US: Twitter @maravipost Facebook Page : maravipost Instagram: maravipost    
Maravi Post Reporter
Maravi Post Reporterhttps://www.maravipost.com/
Op-Ed Columnists, Opinion contributors and one submissions are posted under this Author. In our By-lines we still give Credit to the right Author. However we stand by all reports posted by Maravi Post Reporter.

Most Popular

Recent Comments

The History of online Casinos – Agora Poker – hao029 on The History of online Casinos
Five factors that will determine #NigeriaDecides2023 - NEWSCABAL on Leadership Is Difficult Because Governance Is Very Stubborn, By Owei Lakemfa
Asal Usul Texas Holdem Poker – Agora Poker – hao029 on The Origins of Texas Holdem Poker
Malawi has asked Mike Tyson to be its cannabis ambassador - Techio on Malawi lawmaker Chomanika against Mike Tyson’s appointment as Cannabis Brand Ambassador over sex offence
Finley Mbella on Brand Chakwera leaks Part 1
Maria Eduarda Bernardo on The 2021 Guide to Trading Forex Online
Atsogo Kemso, Political Foot Soldier on Why MCP and UTM Alliance Will Fail
Em. Prof. Willem Van Cotthem - Ghent University, Belgium on Malawi army, National bank cover Chilumba barrack with trees
Christopher Murdock on Why dating older woman is dangerous?
Samantha The Hammer on Why dating older woman is dangerous?
Muhindo Isevahani on The Cold War Against TB Joshua
JCON/SCOAN/BKN(888/8885/8808) on The Cold War Against TB Joshua
Keen Observer on Jesse Kabwila, Then and Now
Francesco Sinibaldi on Advertising in 2020 and beyond